MSD INDIA LAUNCHES CANCIDAS IV ANTI-FUNGAL DRUG IN INDIA

MSD India, a wholly owned subsidiary of Merck & Co. Inc., launched their latest anti fungal drug, Cancidas IV (caspofugin acetate 50mg/ 70mg), in the Indian pharmaceutical market. The drug is priced at US$ 350 per dose. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34943§ionid=)